Mi Yedong, Chen Donglai, Chen Zhangqiang, Li Yue, Dai Xiaoxiao, Shen Shanshan, Shu Jian, Li Yongzhong, Tan Lijie, Mao Yiming, Ding Qifeng, Chen Yongbing
Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, PR China.
Department of Thoracic Surgery, Jiangyin People's Hospital, Wuxi, PR China.
J Pathol Clin Res. 2025 Jul;11(4):e70039. doi: 10.1002/2056-4538.70039.
It has not been determined which descriptor spread through air spaces (STAS) should be incorporated into the context of the ninth Tumor, Node and Metastasis (TNM) staging system: the T or the uncertain resection [R(un)] category. A multicenter retrospective cohort of 807 patients with pathological stage I lung adenocarcinoma was included in this study to assess the feasibility of incorporating STAS into the T descriptor or the R(un) category by analyzing recurrence-free survival (RFS) and overall survival (OS). Decision curve analysis (DCA) was performed to evaluate the standardized net benefit of the proposed T (nT) and that of the proposed residual tumor classification (nR) versus the current staging systems. Log-rank tests indicated that patients with pT1/STAS-positive lung adenocarcinoma had similar RFS and OS to patients with pT2a disease irrespective of R status. Regarding STAS as an indicator for upgrading R0 to R(un), comparable survival was observed between pT1-2a/STAS-positive patients undergoing R0 segmentectomy and pT1-2a patients undergoing R(un) segmentectomy. We further assessed the effects of the combination of STAS with either T or R category on survival in a validation cohort. Subgroup analyses stratified by surgical procedures further identified the consistency of the nT category in discriminating RFS and OS. However, the separation of nR0 and nR(un) disease in pT2a tumors treated by lobectomy or segmentectomy was not sufficiently distinguished. DCA further corroborated a greater predictive capability of nT versus the current T category. In conclusion, STAS might be preferentially considered as an indicator for upgrading pT1 disease into pT2a in the future TNM staging system.
尚未确定在第九版肿瘤、淋巴结和转移(TNM)分期系统中,哪种气腔播散(STAS)描述符应纳入T描述符或不确定切除[R(un)]类别中。本研究纳入了一个多中心回顾性队列,共807例病理I期肺腺癌患者,通过分析无复发生存期(RFS)和总生存期(OS)来评估将STAS纳入T描述符或R(un)类别的可行性。进行决策曲线分析(DCA)以评估提议的T(nT)和提议的残余肿瘤分类(nR)相对于当前分期系统的标准化净效益。对数秩检验表明,无论R状态如何,pT1/STAS阳性肺腺癌患者的RFS和OS与pT2a疾病患者相似。将STAS视为将R0升级为R(un)的指标,在接受R0肺段切除术的pT1-2a/STAS阳性患者和接受R(un)肺段切除术的pT1-2a患者之间观察到了相似的生存率。我们进一步在验证队列中评估了STAS与T或R类别组合对生存的影响。按手术方式分层的亚组分析进一步确定了nT类别在区分RFS和OS方面的一致性。然而,在接受肺叶切除术或肺段切除术的pT2a肿瘤中,nR0和nR(un)疾病的区分不够明显。DCA进一步证实了nT相对于当前T类别的更大预测能力。总之,在未来的TNM分期系统中,STAS可能优先被视为将pT1疾病升级为pT2a的指标。